Thomas K. Equels, CEO, President at HEMISPHERX BIOPHARMA INC (HEB), bought 68,493 shares at $0.73 ($50K) on 2016-12-22, disclosed to the SEC on 2016-12-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AIM | BUY | 2020-12-17 | $25K | — | Filing → |
| AIM | BUY | 2020-09-03 | $25K | — | Filing → |
| AIM | BUY | 2020-08-21 | $25K | — | Filing → |